About Stadmed Pvt Ltd
Data last updated:
Stadmed Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 1951 and has been in existence for over 75 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24234WB1951PTC012791. Its GSTIN is 19AAECS1580Q1ZP (West Bengal). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹22.88 Lakh. It was formerly known as Standard Medical Research Institute Limited and Standard Medical Research Institute Private Limited. It is led by directors including Ashish Roy and Amit Kumar Ray.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 84 Chowringhee Road, Kolkata, West Bengal, India – 700020.
As per the financials filed for FY 2025, the company reported a revenue of ₹112.88 Cr. For the same year it recorded a net profit of ₹11.37 Cr (net margin 10.1%) and EBITDA of ₹19.06 Cr (EBITDA margin 16.9%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 9% over five years.
The company has about 599 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.81 Cr on record. Court records list 63 cases involving the company, including 34 filed by the company and 29 filed against it; 11 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in March 2022. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Synthokem Labs Private Limited with revenue of ₹113.98 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 198 overdue payments to 8 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stadmed-global.com.
Company details
Name history
Stadmed has undergone 2 name changes throughout its history. The company was previously known as Standard Medical Research Institute Limited, and Standard Medical Research Institute Private Limited. The current legal name is Stadmed Pvt Ltd.
| Company Name | Status |
|---|---|
| Stadmed Pvt Ltd | Current |
| Standard Medical Research Institute Limited | Previous |
| Standard Medical Research Institute Private Limited | Previous |
Contact details
Stadmed Pvt Ltd's registered office is in Kolkata, West Bengal. Its website is stadmed-global.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address84 Chowringhee Road, Kolkata, West Bengal, India – 700020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stadmed Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stadmed is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stadmed Pvt Ltd, buy the company report.
Financials of Stadmed Pvt Ltd
FY 2024 filings availableStadmed Pvt Ltd reported revenue of ₹112.88 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.9% | ||||
| Net Profit Margin | 10.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stadmed Pvt Ltd, buy the company report.
Board of directors of Stadmed Pvt Ltd
Stadmed has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Roy Also directs: Synar Trading Private Limited | Director | 19 Mar 1976 | 50 Years 7 Months | Current |
| Amit Kumar Ray | Director | 17 Feb 1979 | 47 Years 8 Months | Current |
| Anjan Roy | Director | 19 Mar 1976 | 50 Years 7 Months | Current |
Peer comparison
Stadmed Pvt Ltd is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synthokem Labs Private Limited | ₹113.98 Cr (FY 2024) | 2.0% | Patancheru, Telangana, India | |||
| Savorite Pharmaceuticals Private Limited | ₹113.71 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Socomed Pharma Private Limited | ₹113.64 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Seagull Pharmaceuticals Pvt Ltd | ₹113.36 Cr (FY 2025) | 8.0% | Naraina Vihar, Delhi, India | |||
| Stadmed Pvt Ltdthis company | ₹112.88 Cr (FY 2025) | ₹11.37 Cr | 10.1% | 599 | Kolkata, West Bengal, India | |
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India | |||
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India | |||
| Apple Formulations Private Limited. | ₹111.56 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Penang Enterprises Private Limited | ₹111.42 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Stadmed Pvt Ltd, buy the company report.
Auditor
Stadmed Pvt Ltd is audited by H.P.MOOKHERJEE & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.P.MOOKHERJEE & CO | FY 2023 | 302099E |
Shareholding
The shareholding of Stadmed Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stadmed Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jul 1988 | 90247692 | Others | ₹14.81 Cr | Open |
To see the full charge records of Stadmed Pvt Ltd, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Stadmed Pvt Ltd has 3 deals on record (3 secondary share transfers); the latest was in March 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stadmed Pvt Ltd has 63 court cases on record: 34 filed by Stadmed, 29 filed against it. 11 cases are pending and 52 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 43 | 16 | 7 |
| District courts | 17 | 13 | 4 |
| Supreme Court | 3 | 0 | 0 |
Cases on record (5 of 63)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMMP) | Filed by the company against Sun Pharma Laboratories Ltd and Anr and 1 other | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Sun Pharma Laboratories Ltd and Anr | Pending |
| High Court | Civil suit | Filed by the company against Sun Pharma Laboratories Limited | Pending |
| High Court | Civil suit | Filed against the company by Sun Pharma Laboratories Ltd. | Pending |
| Bombay High Court | Court case (IMP) | Filed against the company by Sun Pharmaceutical Industries Ltd. | Disposed |
To see the full case history of Stadmed Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Stadmed Pvt Ltd was last rated by Care on 07 Feb 2023.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Feb 2023 |
To see the full credit ratings and regulatory alerts of Stadmed Pvt Ltd, buy the company report.
MSME payment delays
Stadmed Pvt Ltd has 11 MSME Form 1 returns on record between 2019 and 2023, listing 198 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Narayan Chemicals | |||
| an individual supplier | |||
| Biswa Bharati Chemcal Works | |||
| Alpha Plastomers Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Stadmed Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Stadmed Pvt Ltd has a workforce of 599 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Stadmed has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAECS1580Q1ZP | West Bengal | Active | 01 Jul 2017 |
| 19AAECS1580Q2ZO | West Bengal | Active | 08 Nov 2017 |
| 07AAECS1580Q1ZU | Delhi | Active | 01 Jul 2017 |
| 09AAECS1580Q1ZQ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stadmed Pvt Ltd, buy the company report.
Recent activity
Stadmed Pvt Ltd has 7 board changes on record since 1959: 5 appointments and 2 cessations. The latest: Sushil Kumar Roy ceased to be Director on 21 Sep 2025.
Frequently asked questions
Stadmed is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 1951 (75+ years old) and is registered under CIN U24234WB1951PTC012791.
Stadmed has 3 current directors:
- Ashish Roy - Director
- Amit Kumar Ray - Director
- Anjan Roy - Director
The latest financial statements of Stadmed on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stadmed is 19AAECS1580Q1ZP, registered in West Bengal. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 19AAECS1580Q2ZO (West Bengal), 07AAECS1580Q1ZU (Delhi), 09AAECS1580Q1ZQ (Uttar Pradesh).
The CIN (Corporate Identification Number) of Stadmed is U24234WB1951PTC012791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stadmed has 63 court cases on record: 34 filed by the company and 29 filed against it. 11 are pending. Most are in the high courts.
Stadmed was incorporated on 22 June 1951, making it 75+ years old. It is registered with the Registrar of Companies, Kolkata.
Stadmed has 3 deals on record (3 secondary share transfers); the latest was in March 2022.
The peers of Stadmed by revenue are Synthokem Labs Private Limited, Savorite Pharmaceuticals Private Limited, Socomed Pharma Private Limited, Seagull Pharmaceuticals Pvt Ltd, Shree Ganesh Remedies Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sushil Kumar Roy ceased to be Director on 21 Sep 2025. Sujata Saha ceased to be Managing Director on 25 Sep 2016. Amit Kumar Ray was appointed as Director on 17 Feb 1979. Stadmed has 7 board changes on record in total.
Stadmed has 11 MSME Form 1 returns on record between 2019 and 2023, listing 198 overdue payments to 8 micro and small suppliers. The latest return was filed on 29 Aug 2023.
Stadmed can be reached through the website stadmed-global.com. Its registered office is in Kolkata, West Bengal, India.